Davis Capital Management
VCYT icon

Davis Capital Management’s Veracyte VCYT Stock Holding History

Davis Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$92 Sell
2
-2
-50% -$96 ﹤0.01% 1054
2026
Q2 		$235 Buy
+4
New +$168 ﹤0.01% 794

Other funds holding VCYT

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

Davis Capital Management's VCYT Position: Q3 2026 in Review

Davis Capital Management reduced its Veracyte (VCYT) stake by 50% in Q3 2026, selling an estimated $96 and leaving 2 shares worth $92. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

Davis Capital Management first reported a position in VCYT in Q2 2026 and has held it in 2 quarters since. The position peaked at $235 in Q2 2026. 154 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Davis Capital Management held 2 shares of Veracyte worth $92 as of Q3 2026.
  • Davis Capital Management sold 2 Veracyte shares in Q3 2026, an estimated $96.
  • Veracyte made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #1054 holding.
  • Davis Capital Management first reported a position in Veracyte in Q2 2026 and has held it in 2 quarters since.
  • Davis Capital Management's Veracyte position peaked at $235 in Q2 2026.
  • 154 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.